The Discounted Cash Flow (DCF) valuation of Medipharm Labs Corp (LABS.TO) is (0.44) CAD. With the latest stock price at 0.07 CAD, the upside of Medipharm Labs Corp based on DCF is -770.5%.
Based on the latest price of 0.07 CAD and our DCF valuation, Medipharm Labs Corp (LABS.TO) is a sell. selling LABS.TO stocks now will result in a potential gain of 770.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 7.5% - 10.5% | 9.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (0.84) - (0.30) | (0.44) |
| Upside | -1397.1% - -558.3% | -770.5% |